A Cancer Conundrum: Too Many Drug Trials, Too Few Patients – New York Times
New York Times |
A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
New York Times With the arrival of two revolutionary treatment strategies, immunotherapy and personalized medicine, cancer researchers have found new hope — and a problem that is perhaps unprecedented in medical research. There are too many experimental cancer … |
